Bank Of America Corp Dare Bioscience, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $0.61 $233 - $509	835 Added 571.92%	981 $0
Q1 2024 May 15, 2024	SELL	$0.31 - $0.57 $39 - $72	-128 Reduced 46.72%	146 $0
Q4 2023 Feb 14, 2024	BUY	$0.29 - $0.53 $79 - $145	274 New	274 $0
Q4 2022 Feb 10, 2023	BUY	$0.82 - $12.6 $164 - $2,520	200 New	200 $0
Q1 2022 May 16, 2022	BUY	$1.42 - $2.09 $42,135 - $62,016	29,673 New	29,673 $44,000
Q3 2021 Nov 15, 2021	SELL	$1.42 - $2.0 $3,294 - $4,640	-2,320 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$1.21 - $1.89 $2,807 - $4,384	2,320 New	2,320 $4,000

278K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $382M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.